LindströmC.G.‘Collagenous colitis’ with watery diarrhea—a new entity?Pathol Eur1976; 11: 87–9.
2.
ChandeN., DrimanD.K.Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature.Scand J Gastroenterol2007; 42: 530–3.
3.
ThomsonR.D., LestinaL.S., BensenS.P., ToorA., MaheshwariY., RatcliffeN.R.Lansoprazole-associated microscopic colitis: a case series.Am J Gastroenterol2002; 97: 2908–13.
4.
WakasugiM., IchikawaK., HonmaT., WakakiK., HonmaN.A case of collagenous colitis on chronic hemodialysis.J Jpn Soc Dial Ther2010; 43: 999–1003. [in Japanese]
5.
MiyagawaT., UedaT.A case of lansoprazole-associated collagenous colitis in a hemodialysis patient.J Jpn Soc Dial Ther2010; 43: 843–6. [in Japanese]
6.
AllendeD.S., TaylorS.L., BronnerM.P.Colonic perforation as a complication of collagenous colitis in a series of 12 patients.Am J Gastroenterol2008; 103: 2598–604.
7.
BohrJ., LarssonL.G., ErikssonS., JärnerotG., TyskC.Colonic perforation in collagenous colitis: an unusual complication.Eur J Gastroenterol Hepatol2005; 17: 121–4.
8.
BhattD.L., ScheimanJ., AbrahamN.S., AntmanE.M., ChanF.K., FurbergC.D.ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.Circulation2008; 118: 1894–909.
9.
AriizumiK., OharaS., KoikeT., InomataY., IijimaK., SekineH.Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism.J Gastroenterol Hepatol2006; 21: 1428–34.
10.
AndersonJ.E., YimK.B., CrowellM.D.Prevalence of gastroesophageal reflux disease in peritoneal dialysis and hemodialysis patients.Adv Perit Dial1999; 15: 75–8.
